Joe Biden had proposed a rule in late November after Trump won re-election that would have extended coverage of drugs meant ...

President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the federal ...

Health and Human Services Secretary Robert F. Kennedy Jr. has been critical of the drugs, instead placing a focus on ...

The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...

The Trump administration's Center for Medicare and Medicaid Services (CMS) has chosen not to finalize a rule proposed by the Biden administration in November that would have allowed Medicare to cover ...

Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.

Shares of Eli Lilly, the seller of Zepbound, were down 2.7% to $718.50 after the close on Friday. Novo Nordisk, the maker of Wegovy, saw its stock decline 1.4% to $61.67. Shares of Hims & Hers, a ...

The Biden administration had proposed late last year coverage of the popular medicines for obesity.

The Trump administration has decided not to back a Biden administration plan that would have allowed Medicare to pay for ...

The Dietary Guidelines for America are due by the end of the year, but Trump administration statements raise doubts as to ...

Priced at INR 2000 per month or INR 5000 for a 3-month course, the Advanced Metabolic System is accessible through online and offline channels.

We all know the problems with American healthcare. It costs too much, there are gaps in insurance coverage, healthcare ...